What Is a Femorofemoral Bypass and How Long Does It Last?

A femorofemoral bypass is a surgical procedure that reroutes blood from one leg’s femoral artery to the other, bypassing a blockage in the iliac artery on the affected side. It belongs to a category of operations called extra-anatomic bypasses, meaning the graft takes a path outside the body’s normal arterial anatomy rather than replacing the diseased vessel in place. The operation is less invasive than the gold-standard aortobifemoral bypass, which is a major abdominal procedure, and that trade-off between lower surgical stress and somewhat lower long-term durability defines much of how surgeons think about it.

Who Needs This Procedure

Femorofemoral bypass is primarily used for people with blockages in one iliac artery, the large vessel that carries blood from the aorta down to each leg. The symptoms it treats range from intermittent claudication, the cramping leg pain that comes on with walking and eases with rest, to critical limb ischemia, where the leg is in danger of tissue loss or gangrene. The procedure is generally reserved for patients whose blockage can’t be fixed with a catheter-based approach like stenting and who also aren’t healthy enough to tolerate the much larger aortobifemoral reconstruction, which involves clamping the aorta through an abdominal incision.1The Thoracic and Cardiovascular Surgeon. An Overview and Update of Femorofemoral Crossover Bypass Surgery as an Extra-Anatomic Bypass Procedure In practice, that means many of these patients are older, have significant heart or lung disease, or have had previous abdominal surgeries that make a repeat open approach risky.

A key anatomic requirement is that the iliac artery on the donor side, the side supplying blood, must be reasonably healthy. The whole concept depends on one side having enough flow to share with the other. If both iliac arteries are severely diseased, a femorofemoral bypass won’t work, and the surgeon needs to consider a different approach entirely, such as an axillofemoral bypass from the arm’s artery or, when possible, the aortobifemoral route.

How the Procedure Works

The surgeon makes incisions in both groins to expose the common femoral arteries. A synthetic tube graft, typically around 8 millimeters in diameter, is tunneled across the lower abdomen from the donor femoral artery to the recipient femoral artery. The graft can be routed either just beneath the skin in the subcutaneous fat or deeper, in the preperitoneal plane just in front of the abdominal lining. One study comparing these two approaches found that the deeper preperitoneal placement was associated with better long-term graft function and fewer infections than the subcutaneous route.2Vascular Surgery. Femorofemoral Arterial Bypass: Subcutaneous or Preperitoneal That said, the subcutaneous tunnel remains common because it’s technically simpler and allows easier access if the graft ever needs to be revised.

The two most widely used graft materials are PTFE (a Teflon-like polymer) and Dacron (a polyester fabric). A randomized trial comparing these materials in femorofemoral bypasses found no meaningful difference in how long the grafts stayed open. At one year, both types had patency rates in the low-to-mid 90% range, and at two years the rates remained comparable.3PubMed. Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial The choice between them often comes down to surgeon preference and the specific clinical situation rather than any major performance gap.

How Long the Graft Lasts

Durability is the central question for any bypass graft, and femorofemoral bypasses perform reasonably well in the medium term but show meaningful attrition over many years. One long-term study reported primary patency, meaning the graft stayed open without any additional procedures, of about 89% at one year, 70% at five years, and 31% at ten years. When secondary interventions to rescue a failing graft were included, those numbers improved to 97%, 85%, and 67% at the same time points.4PubMed Central. Long Term Outcomes of Femorofemoral Crossover Bypass Grafts Another study of crossover grafts found three-year and five-year primary patency rates of roughly 73% and 65%.5PubMed. Factors affecting the long-term patency of crossover femorofemoral bypass graft

What those numbers mean practically is that the graft works well for the first several years, and then the failure rate climbs. But the gap between primary and secondary patency is telling: many grafts that run into trouble can be salvaged with a relatively minor procedure, like a revision or a catheter-based intervention, rather than needing a completely new bypass. That makes ongoing surveillance especially important.

Limb salvage, arguably the outcome that matters most to patients facing potential amputation, holds up better than patency numbers alone would suggest. Five-year limb salvage rates of about 85% and ten-year rates around 80% have been reported, meaning that even when a graft eventually fails, the leg is often preserved through other means.6PubMed. Femorofemoral bypass grafts: Factors influencing long-term patency rate and outcome There’s an important caveat here: patients who receive a femorofemoral bypass after a previous vascular graft has already failed do considerably worse. Ten-year secondary patency dropped by roughly half in patients with prior graft failures, and limb salvage was also lower.7PubMed. Femorofemoral bypass grafts: Factors influencing long-term patency rate and outcome

When the arteries below the graft in the recipient leg are heavily diseased, some surgeons perform additional outflow procedures at the same time, such as a bypass to the popliteal or tibial arteries further down the leg. Research suggests that adding these outflow operations compensates for the negative impact of having those downstream blockages and improves graft durability.8Journal of Vascular Surgery. Femorofemoral bypass grafts: Analysis of patency and factors influencing long-term outcome

Compared to Aortobifemoral Bypass

The aortobifemoral bypass, which brings blood from the aorta down to both femoral arteries through the abdomen, is the more durable operation. A comparative study found three-year patency of about 85% for aortobifemoral bypass versus 60% for femorofemoral bypass. However, both procedures achieved limb salvage above 85% at three years.9PubMed. Femorofemoral versus aortobifemoral bypass: outcome and hemodynamic results The trade-off is straightforward: the bigger operation keeps the graft open longer, but the smaller one saves limbs nearly as often while being far easier on the body. For patients with serious heart, lung, or kidney disease, or those with a hostile abdomen from prior surgeries, that easier recovery isn’t a minor consideration.

A separate study comparing these two approaches in matched groups actually found narrower differences than the previous one: five-year primary patency was about 71% for femorofemoral bypass and 80% for aortobifemoral bypass, with limb salvage and mortality rates that were statistically similar between the groups.10PubMed. Comparison of femorofemoral and aortofemoral bypass for aortoiliac occlusive disease The range in these findings likely reflects differences in patient selection and surgical technique across institutions, but the overall picture is consistent: femorofemoral bypass trades some durability for a less demanding procedure.

Compared to Endovascular Stenting

The rise of catheter-based techniques, particularly iliac artery stenting, has changed the landscape considerably. Stenting is less invasive still, requiring only a needle puncture rather than open incisions, and patients go home much faster. A recent retrospective study comparing femorofemoral bypass with endovascular treatment for iliac artery occlusions found that both achieved similar long-term limb salvage of about 94% at eight years. Endovascular treatment had shorter hospital stays, averaging about one and a half days compared to roughly eight days for the surgical group, and lower rates of perioperative complications.11PubMed Central. Long-Term Outcomes of Femorofemoral Crossover Bypass Versus Endovascular Revascularization in Iliac Artery Occlusions: A Retrospective Study

The trade-offs were more nuanced than a simple win for stenting, though. The surgical bypass group had lower restenosis rates (about 6% versus 20% for stenting), suggesting less need for maintenance interventions to keep the vessel open. However, the bypass group had a higher rate of complete graft occlusion (roughly 20% versus 7%). In other words, stents narrow gradually and need touch-up procedures more often, while grafts tend to either work or clot off entirely.12PubMed Central. Long-Term Outcomes of Femorofemoral Crossover Bypass Versus Endovascular Revascularization in Iliac Artery Occlusions: A Retrospective Study For patients who are good candidates for stenting, it’s usually tried first. Femorofemoral bypass steps in when the anatomy isn’t suitable for stenting, when stenting has already failed, or when the blockage is too long or complex for a catheter-based fix.

Cost follows a similar pattern. An analysis of iliac stenting versus crossover grafting found that stenting was initially cheaper, with estimated costs roughly 60% of the surgical option. But the cost advantage evaporated quickly. Patients who developed complications after stenting lost the cost benefit entirely, and even among uncomplicated cases, the savings disappeared within about six months as stent failures required further procedures, often the crossover graft itself.13PubMed. Iliac occlusions: stenting or crossover grafting? An examination of patency and cost

The Steal Syndrome Problem

One concern unique to femorofemoral bypass is the possibility that diverting blood through the graft to the recipient leg could deprive the donor leg of adequate flow, a phenomenon called steal syndrome. The risk arises when the donor iliac artery has some degree of unrecognized disease that becomes hemodynamically significant once it’s asked to supply both legs instead of just one.

An early study on this found that measuring the resistance in the donor artery during surgery could predict who would develop steal. Patients with low inflow resistance had no complications, while those with higher resistance values developed measurable or clinically apparent steal, where the donor leg actually gets worse after surgery.14PubMed. Intra-operative inflow resistance measurement: a predictor of steal syndromes following femoro-femoral bypass grafting Noninvasive testing after surgery can also detect steal: in patients with poor outflow in the donor limb, ankle pressures dropped significantly after exercise, suggesting blood was being diverted away from the donor leg to supply the recipient side through the graft.15PubMed. Non-invasive assessment of the steal phenomenon following femoro-femoral bypass

The practical lesson is that surgeons need to carefully evaluate the donor iliac artery before and during the operation. If there’s any significant disease on that side, additional procedures to improve donor inflow, like stenting the donor iliac artery or performing an endarterectomy, should be considered at the time of surgery rather than risking a steal problem afterward.16PubMed. Non-invasive assessment of the steal phenomenon following femoro-femoral bypass Preoperative pressure measurements across the donor iliac artery can help predict outcomes, though one study cautioned that these measurements have enough variability between patients that they shouldn’t be the sole basis for deciding whether to proceed.17PubMed. The value of donor iliac artery pressure gradients in predicting the outcome of femorofemoral bypass

Complications Beyond Steal

Like any operation involving a synthetic graft, femorofemoral bypass carries a risk of graft infection. Because the graft tunnels through the groin on both sides, and the groin is a warm, moist area with skin bacteria nearby, infection rates for extra-anatomic grafts are a genuine concern. When groin infections do occur, the microbiology is varied. One series found Staphylococcus aureus in about 42% of infected grafts, with Staphylococcus epidermidis, E. coli, and a range of other organisms accounting for the rest. About a quarter of infected grafts grew more than one bacterial species.18JAMA Surgery. Infrascrotal, Perineal, Femorofemoral Bypass for Arterial Graft Infection at the Groin When infection is limited to one groin, creative rerouting strategies exist, such as running a new graft through an infrascrotal or perineal tunnel to avoid the contaminated field.

Pseudoaneurysm formation, where the connection between the graft and the artery develops a leaking bulge, is another late complication. One reported case involved a Dacron graft that developed a contained rupture forming a large pseudoaneurysm, ultimately requiring graft removal and replacement with an axillofemoral bypass. The explanted graft showed complete material degradation, and cultures grew a gram-negative bacterium, suggesting that low-grade infection contributed to the graft’s structural failure.19Journal of Surgery. Spontaneous Pseudoaneurysm of Femorofemoral Crossover Bypass: A Case Report While dramatic cases like this are uncommon, they underscore why patients with any bypass graft should stay in follow-up indefinitely.

Anesthesia Options

Because femorofemoral bypass is often performed on patients who are considered too high-risk for major abdominal surgery, the choice of anesthesia matters. General anesthesia is the most common approach, but it carries higher complication rates in this population. Regional techniques, including spinal and epidural anesthesia, are viable alternatives that reduce some of the cardiopulmonary stress of the operation.20PubMed Central. Quadratus lumborum block for femoral–femoral bypass graft placement Newer peripheral nerve block techniques, such as the quadratus lumborum block, have also been described as ways to manage the surgery without general or central neuraxial anesthesia, which can be appealing for patients on blood thinners who can’t safely receive a spinal or epidural. The ability to perform this operation under various anesthetic techniques is part of what makes it adaptable to very sick patients.

Keeping Tabs on the Graft

Routine surveillance with duplex ultrasound, a noninvasive imaging method that combines standard ultrasound with blood-flow velocity measurements, plays an important role in catching graft problems before the graft clots off entirely. A study of femorofemoral bypasses specifically found that a peak velocity above 300 centimeters per second within the graft or the donor iliac artery identified grafts at risk of failure, and repairing those lesions when detected resulted in strong five-year patency.21PubMed. Duplex ultrasound criteria for femorofemoral bypass revision

The value of surveillance over simpler monitoring was demonstrated in a broader study of prosthetic grafts, which found that duplex ultrasound detected about 81% of failing grafts before they clotted, compared to only 24% detected by non-ultrasound methods like ankle pressure checks alone. The chance of a graft clotting despite a normal surveillance test was just 7% with duplex versus 21% without it.22PubMed. Duplex ultrasonography to diagnose failing arterial prosthetic grafts For patients, the practical message is that scheduled follow-up visits with ultrasound are not optional niceties. They’re the early-warning system that turns a graft heading toward failure into a graft that gets a timely fix.

Blood Thinners After Surgery

What medications patients should take to keep the graft open is less settled than you might expect. Most vascular surgeons prescribe at least one antiplatelet agent, usually aspirin, but practices vary on whether to add a second antiplatelet drug or switch to a full anticoagulant like warfarin. A study looking specifically at extra-anatomic bypasses, including femorofemoral grafts, found that one-year primary patency was about 86% and did not differ significantly based on whether patients received anticoagulation or dual antiplatelet therapy.23PubMed. Selective Use of Anticoagulation or Dual Antiplatelet Therapy for Patients with Extra-anatomic Bypasses The result suggests that more aggressive blood-thinning regimens don’t clearly outperform simpler ones for these grafts, though the study was observational and the decision is still often tailored to individual patient factors like the quality of runoff, the reason for the bypass, and bleeding risk.

When Femorofemoral Bypass Serves as a Rescue

Beyond its primary role as an elective revascularization for iliac disease, femorofemoral bypass shows up in several less common but important scenarios. It can function as a salvage procedure when a previous aortobifemoral graft becomes infected on one side: the infected limb of the old graft is removed, and a new femorofemoral graft is tunneled through a clean tissue plane to restore flow from the still-functioning side. It can also serve as a temporary or permanent conduit during complex aortic or iliac reconstructions where one leg’s blood supply needs to be maintained while the other side is being repaired.

In the context of graft infection management, the perineal or infrascrotal tunnel routes allow the new crossover graft to avoid the contaminated groin entirely. This kind of creative re-routing is one of the strengths of the femorofemoral concept: because the graft is superficial and doesn’t require entering the abdomen, surgeons have flexibility to choose paths through uninfected tissue.24JAMA Surgery. Infrascrotal, Perineal, Femorofemoral Bypass for Arterial Graft Infection at the Groin The trade-off is that each reoperation adds cumulative risk, and outcomes are consistently worse in patients who have already had one or more graft failures.